출판 : MarketsandMarkets (마켓츠앤마켓츠) 출판년월 : 2023년01월
환자 포지셔닝 시스템(Patient Positioning Systems) 시장 : 제품 [테이블(수술대, 이미징 테이블, 검사대), 액세서리, 용도(수술, 진단, 암 치료), 최종 사용자(병원, ASC, 진단 실험실)] – 2027년까지의 세계 예측
Patient Positioning Systems Market by Product (Tables (Surgical Table, Imaging Table, Examination Table), Accessories, Application (Surgery, Diagnosis, Cancer Treatment), End User (Hospitals, ASCs, Diagnostic Labs)) – Global Forecast to 2027
페이지수 | 198 |
도표수 | 186 |
구성 | 영문조사보고서 |
가격 |
The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 from USD 1.4 billion in 2022, growing at a CAGR of 4.0% during the forecast period. The availability of government support, in funds and grants, for infrastructural development in the hospital and medical sectors is the key factor supporting market growth.
전 세계 환자 포지셔닝 시스템 시장은 예측 기간 동안 연평균 4.0% 성장하여 2022년 14억 달러에서 2027년까지 17억 달러에 이를 것으로 예상됩니다. 병원 및 의료 부문의 인프라 개발을 위한 정부 지원(기금 및 보조금)의 가용성은 시장 성장을 지원하는 핵심 요소입니다.
“The surgical tables segment to hold the largest share of the market in 2022”
Based on the product, the patient positioning systems market is segmented into tables, accessories, and other patient positioning systems. The tables market is further segmented into surgical table, radiolucent imaging table, and examination table. The surgical tables segment accounted for the largest market share in 2021. The usage of these tables is slated to increase in the coming years due to the increasing number of surgeries.
“The cancer therapy segment is projected to register the highest CAGR during the forecast period”
Based on application, the patient positioning systems market is segmented into surgeries, disease diagnosis and cancer therapy. By application, cancer therapy segment is anticipated to register the highest CAGR during the forecast period. The key factor driving this application segment’s growth is the rising cancer prevalence and the growing demand for cancer treatment. According to GLOBOCAN, the incidence of all types of cancers, excluding non-melanoma skin cancer, in 2020 was 19.3 million; it is expected to reach 28.4 million by 2040, a 47% rise from 2020.
“The ambulatory surgical centers segment is projected to register the highest CAGR during the forecast period”
Based on end users, the global patient positioning systems market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and other end users. By end users, ambulatory surgical centers segment is projected to register the highest CAGR during the forecast period. ASCs significantly help improve the quality of care while simultaneously reducing the cost of procedures. As a result of these advantages, an increasing number of patients are opting to undergo procedures at ASCs. According to the ASCA (Ambulatory Surgery Center Association), more than 5,300 ASCs perform around 23 million surgeries annually in the US.
“The market in the North America region is expected to hold significant market share for patient positioning systems in 2022.”
The patient positioning systems market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in the North America region is expected to hold significant market share for patient positioning systems in 2022. The rising number of surgical procedures is the major factor driving the growth of the North American patient positioning systems market. The growing geriatric population and rising prevalence of lifestyle diseases such as arthritis and obesity in this region are key contributors to the growth of the patient positioning system.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
The prominent players in the patient positioning systems market are Hill-Rom, Inc. (US), Elekta AB (Sweden), Span America Medical Systems, Inc. (US), Smith & Nephew plc (UK), MERIVAARA CORPORATION (Finland), CIVCO (US), Guangzhou Renfu Medical Equipment CO, LTD (China), Medline Industries, LP. (US), LEONI AG (Germany), Getinge AB (Germany), C-RAD (Sweden), Stryker Corporation (US), Steris Plc. (US), Medtronic PLC (US), Mizuho OSI (US), ORFIT INDUSTRIES N.V. (Belgium), and Oncotech (Turkey) among others.
Research Coverage
This report studies the patient positioning systems market based on product, application, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the patient positioning systems market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the patient positioning systems market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the patient positioning systems market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
목차
1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 INCLUSIONS AND EXCLUSIONS 28
1.4 MARKET COVERED 28
1.4.1 MARKETS COVERED 28
1.4.2 YEARS CONSIDERED 29
1.5 CURRENCY CONSIDERED 29
1.6 LIMITATIONS 29
1.7 STAKEHOLDERS 30
1.8 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH APPROACH 32
2.2 RECESSION IMPACT 32
2.3 RESEARCH DESIGN 33
2.3.1 SECONDARY RESEARCH 33
2.3.2 PRIMARY RESEARCH 34
2.3.2.1 Primary sources 35
2.3.2.2 Key industry insights 36
2.3.2.3 Breakdown of primaries 36
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 36
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
2.4 MARKET SIZE ESTIMATION 37
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38
2.4.1 BOTTOM-UP APPROACH 38
2.4.1.1 Approach 1: Company revenue estimation approach 39
2.4.1.2 Approach 2: Customer-based market estimation 39
FIGURE 4 PATIENT POSITIONING SYSTEMS MARKET: BOTTOM-UP APPROACH FOR MARKET SIZE ESTIMATION 39
2.4.1.3 Growth forecast 40
2.4.1.4 CAGR projection 40
FIGURE 5 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 40
2.5 DATA TRIANGULATION APPROACH 41
FIGURE 6 DATA TRIANGULATION METHODOLOGY 41
2.6 MARKET SHARE 42
2.7 STUDY ASSUMPTIONS 42
2.8 RISK ASSESSMENT 43
2.8.1 PATIENT POSITIONING SYSTEMS MARKET: RISK ASSESSMENT 43
2.9 PATIENT POSITIONING SYSTEMS MARKET: GROWTH RATE ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
FIGURE 7 PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 44
FIGURE 8 PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2022 VS. 2027 (USD MILLION) 45
FIGURE 9 PATIENT POSITIONING SYSTEMS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 45
FIGURE 10 PATIENT POSITIONING SYSTEMS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 46
FIGURE 11 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 47
4 PREMIUM INSIGHTS 48
4.1 PATIENT POSITIONING SYSTEMS MARKET OVERVIEW 48
FIGURE 12 RISING TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICES AND GROWING SURGICAL PROCEDURES TO DRIVE MARKET 48
4.2 NORTH AMERICA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE 49
FIGURE 13 RADIOLUCENT TABLES TO REGISTER HIGH GROWTH IN NORTH AMERICAN MARKET 49
4.3 ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET, BY APPLICATION 49
FIGURE 14 CANCER THERAPY APPLICATION SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 49
4.4 EUROPE: PATIENT POSITIONING SYSTEMS MARKET SHARE, BY END USER, 2022 VS. 2027 50
FIGURE 15 HOSPITALS AND CLINICS SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 50
4.5 GEOGRAPHICAL SNAPSHOT OF PATIENT POSITIONING SYSTEMS MARKET 50
FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 17 PATIENT POSITIONING SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
5.2.1 DRIVERS 52
5.2.1.1 Rising technological advancements in medical devices 52
5.2.1.2 Increasing surgical procedures due to growing burden of chronic diseases 52
5.2.1.3 Rising government funds for hospital expansions 52
5.2.1.4 Growing incidence of sports and accident-related injuries 53
5.2.2 RESTRAINTS 53
5.2.2.1 Product recalls 53
5.2.2.2 Implementation of excise duty on taxable medical devices 54
5.2.3 OPPORTUNITIES 54
5.2.3.1 Emerging markets 54
5.2.4 CHALLENGES 54
5.2.4.1 Availability of refurbished patient positioning systems 54
5.3 PORTER’S FIVE FORCES ANALYSIS 55
TABLE 1 PATIENT POSITIONING SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 55
5.3.1 THREAT OF NEW ENTRANTS 55
5.3.2 THREAT OF SUBSTITUTES 55
5.3.3 BARGAINING POWER OF SUPPLIERS 55
5.3.4 BARGAINING POWER OF BUYERS 55
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 56
5.4 VALUE CHAIN ANALYSIS 56
5.4.1 RESEARCH & DEVELOPMENT 56
5.4.2 PROCUREMENT AND PRODUCT DEVELOPMENT 56
5.4.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES 56
FIGURE 18 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 57
5.5 SUPPLY CHAIN ANALYSIS 57
5.5.1 PROMINENT COMPANIES 57
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES 57
5.5.3 END USERS 57
TABLE 2 SUPPLY CHAIN ECOSYSTEM 58
FIGURE 19 SUPPLY CHAIN ANALYSIS 59
5.6 ECOSYSTEM COVERAGE FOR MEDICAL INSTRUMENTATION 59
5.7 PATENT ANALYSIS 60
FIGURE 20 PATENT DETAILS FOR PATIENT POSITIONING SYSTEMS (JANUARY 2012–OCTOBER 2022) 60
FIGURE 21 PATENT DETAILS FOR SURGICAL TABLES (JANUARY 2012–OCTOBER 2022) 61
FIGURE 22 PATENT DETAILS FOR RADIOLUCENT IMAGING TABLES (JANUARY 2012–OCTOBER 2022) 62
FIGURE 23 PATENT DETAILS FOR EXAMINATION TABLES (JANUARY 2012–OCTOBER 2022) 63
FIGURE 24 PATENT DETAILS FOR PATIENT IMMOBILIZATION (JANUARY 2012–OCTOBER 2022) 64
5.8 TRADE ANALYSIS 65
5.8.1 PATIENT POSITIONING SYSTEMS: TRADE ANALYSIS 65
TABLE 3 IMPORT DATA FOR PATIENT POSITIONING SYSTEMS (HS CODE 940290) BY COUNTRY, 2017–2021 (USD) 65
TABLE 4 EXPORT DATA FOR PATIENT POSITIONING SYSTEMS (HS CODE 940290) BY COUNTRY, 2017–2021 (USD) 65
5.9 KEY CONFERENCES AND EVENTS (2022–2024) 66
TABLE 5 PATIENT POSITIONING SYSTEMS MARKET: KEY CONFERENCES AND EVENTS 66
5.10 PATIENT POSITIONING SYSTEMS MARKET: TECHNOLOGY ANALYSIS 67
6 PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT 69
6.1 INTRODUCTION 70
TABLE 6 PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 70
6.2 TABLES 70
6.2.1 RISING DEMAND FOR SURGICAL TABLES IN CARDIOVASCULAR AND GYNECOLOGICAL PROCEDURES TO DRIVE MARKET 70
TABLE 7 PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 8 PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY REGION, 2020–2027 (USD MILLION) 71
TABLE 9 PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY APPLICATION, 2020–2027 (USD MILLION) 71
TABLE 10 PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY END USER, 2020–2027 (USD MILLION) 72
6.2.2 SURGICAL TABLES 72
6.2.2.1 Rising MIS procedures to drive demand 72
TABLE 11 PATIENT POSITIONING SYSTEMS MARKET FOR SURGICAL TABLES, BY REGION, 2020–2027 (USD MILLION) 73
TABLE 12 PATIENT POSITIONING SYSTEMS MARKET FOR SURGICAL TABLES, BY APPLICATION, 2020–2027 (USD MILLION) 73
TABLE 13 PATIENT POSITIONING SYSTEMS MARKET FOR SURGICAL TABLES, BY END USER, 2020–2027 (USD MILLION) 73
6.2.3 RADIOLUCENT IMAGING TABLES 74
6.2.3.1 Rising number of image-guided procedures to drive uptake 74
TABLE 14 PATIENT POSITIONING SYSTEMS MARKET FOR RADIOLUCENT IMAGING TABLES, BY REGION, 2020–2027 (USD MILLION) 74
TABLE 15 PATIENT POSITIONING SYSTEMS MARKET FOR RADIOLUCENT IMAGING TABLES, BY APPLICATION, 2020–2027 (USD MILLION) 74
TABLE 16 PATIENT POSITIONING SYSTEMS MARKET FOR RADIOLUCENT IMAGING TABLES, BY END USER, 2020–2027 (USD MILLION) 75
6.2.4 EXAMINATION TABLES 75
6.2.4.1 Increasing patient footfall at hospitals and clinics to drive market 75
TABLE 17 PATIENT POSITIONING SYSTEMS MARKET FOR EXAMINATION TABLES, BY REGION, 2020–2027 (USD MILLION) 75
TABLE 18 PATIENT POSITIONING SYSTEMS MARKET FOR EXAMINATION TABLES, BY APPLICATION, 2020–2027 (USD MILLION) 76
TABLE 19 PATIENT POSITIONING SYSTEMS MARKET FOR EXAMINATION TABLES, BY END USER, 2020–2027 (USD MILLION) 76
6.3 ACCESSORIES 76
TABLE 20 PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 77
TABLE 21 PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY REGION, 2020–2027 (USD MILLION) 77
TABLE 22 PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY APPLICATION, 2020–2027 (USD MILLION) 77
TABLE 23 PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY END USER, 2020–2027 (USD MILLION) 78
6.3.1 RADIOTHERAPY/IMMOBILIZATION FIXATION PRODUCTS 78
6.3.1.1 Utilization of imaging cameras in radiation treatment to support market growth 78
TABLE 24 PATIENT POSITIONING SYSTEMS MARKET FOR RADIOTHERAPY IMMOBILIZATION/ FIXATION PRODUCTS, BY REGION, 2020–2027 (USD MILLION) 79
TABLE 25 PATIENT POSITIONING SYSTEMS MARKET FOR RADIOTHERAPY IMMOBILIZATION/ FIXATION PRODUCTS, BY APPLICATION, 2020–2027 (USD MILLION) 79
TABLE 26 PATIENT POSITIONING SYSTEMS MARKET FOR RADIOTHERAPY IMMOBILIZATION/ FIXATION PRODUCTS, BY END USER, 2020–2027 (USD MILLION) 79
6.3.2 OTHER ACCESSORIES 80
TABLE 27 PATIENT POSITIONING SYSTEMS MARKET FOR OTHER ACCESSORIES, BY REGION, 2020–2027 (USD MILLION) 80
TABLE 28 PATIENT POSITIONING SYSTEMS MARKET FOR OTHER ACCESSORIES, BY APPLICATION, 2020–2027 (USD MILLION) 80
TABLE 29 PATIENT POSITIONING SYSTEMS MARKET FOR OTHER ACCESSORIES, BY END USER, 2020–2027 (USD MILLION) 81
6.4 OTHER PATIENT POSITIONING SYSTEMS 81
TABLE 30 PATIENT POSITIONING SYSTEMS MARKET FOR OTHERS, BY REGION, 2020–2027 (USD MILLION) 81
TABLE 31 PATIENT POSITIONING SYSTEMS MARKET FOR OTHERS, BY APPLICATION, 2020–2027 (USD MILLION) 82
TABLE 32 PATIENT POSITIONING SYSTEMS MARKET FOR OTHERS, BY END USER, 2020–2027 (USD MILLION) 82
7 PATIENT POSITIONING SYSTEMS MARKET, BY APPLICATION 83
7.1 INTRODUCTION 84
TABLE 33 PATIENT POSITIONING SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 84
7.2 SURGERY 84
7.2.1 GROWING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET 84
TABLE 34 PATIENT POSITIONING SYSTEMS MARKET FOR SURGERY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 85
7.3 DISEASE DIAGNOSIS 85
7.3.1 RISING USE OF DIAGNOSTIC MODALITIES FOR ACCURATE RESULTS TO DRIVE MARKET 85
TABLE 35 PATIENT POSITIONING SYSTEMS MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 86
7.4 CANCER THERAPY 86
7.4.1 GROWING DEMAND FOR PRECISION THERAPY IN TUMOUR TREATMENT TO DRIVE MARKET 86
TABLE 36 PATIENT POSITIONING SYSTEMS MARKET FOR CANCER THERAPY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 87
8 PATIENT POSITIONING SYSTEMS MARKET, BY END USER 88
8.1 INTRODUCTION 89
TABLE 37 PATIENT POSITIONING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION) 89
8.2 HOSPITALS AND CLINICS 89
8.2.1 INCREASING NUMBER OF SURGICAL PROCEDURES PERFORMED IN HOSPITALS TO DRIVE MARKET 89
TABLE 38 PATIENT POSITIONING SYSTEMS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 90
8.3 AMBULATORY SURGICAL CENTERS 90
8.3.1 RISING PREFERENCE FOR OUTPATIENT PROCEDURES AT LOW COST TO DRIVE MARKET 90
TABLE 39 PATIENT POSITIONING SYSTEMS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2027 (USD MILLION) 91
8.4 DIAGNOSTIC LABORATORIES 91
8.4.1 INCREASING NEED FOR DIAGNOSTIC IMAGING IN EARLY DISEASE DETECTION TO SUPPORT MARKET GROWTH 91
TABLE 40 PATIENT POSITIONING SYSTEMS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 92
8.5 OTHER END USERS 92
TABLE 41 PATIENT POSITIONING SYSTEMS MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 92
9 PATIENT POSITIONING SYSTEMS MARKET, BY REGION 93
9.1 INTRODUCTION 94
TABLE 42 PATIENT POSITIONING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 94
9.2 NORTH AMERICA 94
FIGURE 25 NORTH AMERICA: PATIENT POSITIONING SYSTEMS MARKET SNAPSHOT 95
TABLE 43 NORTH AMERICA: PATIENT POSITIONING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 44 NORTH AMERICA: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 96
TABLE 45 NORTH AMERICA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 46 NORTH AMERICA: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 47 NORTH AMERICA: PATIENT POSITIONING SYSTEM MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97
TABLE 48 NORTH AMERICA: PATIENT POSITIONING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION) 97
9.2.1 US 97
9.2.1.1 Increasing healthcare development activities to drive market 97
TABLE 49 US: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 98
TABLE 50 US: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 51 US: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 98
9.2.2 CANADA 99
9.2.2.1 Investments and government expenditure on healthcare to propel market 99
TABLE 52 CANADA: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99
TABLE 53 CANADA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 54 CANADA: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 100
9.3 EUROPE 100
TABLE 55 EUROPE: PATIENT POSITIONING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 56 EUROPE: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102
TABLE 57 EUROPE: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 58 EUROPE: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 59 EUROPE: PATIENT POSITIONING SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103
TABLE 60 EUROPE: PATIENT POSITIONING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION) 103
9.3.1 GERMANY 103
9.3.1.1 Rising number of hip and knee replacements to support market 103
TABLE 61 GERMANY: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104
TABLE 62 GERMANY: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 63 GERMANY: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 104
9.3.2 FRANCE 105
9.3.2.1 Rising number of road accidents to fuel uptake 105
TABLE 64 FRANCE: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105
TABLE 65 FRANCE: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 66 FRANCE: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 106
9.3.3 UK 106
9.3.3.1 Increase in government healthcare expenditure to boost market 106
TABLE 67 UK: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 106
TABLE 68 UK: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 69 UK: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 107
9.3.4 ITALY 107
9.3.4.1 Increasing medical advancements and hospital accommodations to support market growth 107
TABLE 70 ITALY: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 108
TABLE 71 ITALY: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 72 ITALY: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 109
9.3.5 SPAIN 109
9.3.5.1 Growing hospital admission due to rising disease burden to drive market 109
TABLE 73 SPAIN: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109
TABLE 74 SPAIN: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 75 SPAIN: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 110
9.3.6 REST OF EUROPE 110
TABLE 76 REST OF EUROPE: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111
TABLE 77 REST OF EUROPE: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 78 REST OF EUROPE: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 111
10 PATIENT POSITIONING SYSTEMS MARKET, BY REGION 112
10.1 ASIA PACIFIC 112
FIGURE 26 ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET SNAPSHOT 113
TABLE 79 ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 80 ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 114
TABLE 81 ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 82 ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 83 ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
TABLE 84 ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION) 115
10.1.1 CHINA 116
10.1.1.1 Increasing incidence of non-communicable diseases to drive uptake 116
TABLE 85 CHINA: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 116
TABLE 86 CHINA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 87 CHINA: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 117
10.1.2 JAPAN 117
10.1.2.1 Rising healthcare spending on adoption of advanced medical devices to drive market 117
TABLE 88 JAPAN: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 118
TABLE 89 JAPAN: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 90 JAPAN: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 118
10.1.3 INDIA 119
10.1.3.1 Rising healthcare investments to drive market 119
TABLE 91 INDIA: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 92 INDIA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 93 INDIA: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 120
10.1.4 AUSTRALIA 120
10.1.4.1 Accessible and affordable healthcare services to drive uptake of patient positioning systems 120
TABLE 94 AUSTRALIA: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121
TABLE 95 AUSTRALIA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 96 AUSTRALIA: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 121
10.1.5 SOUTH KOREA 122
10.1.5.1 Increasing incidence of orthopedic disorders to support market growth 122
TABLE 97 SOUTH KOREA: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 98 SOUTH KOREA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 99 SOUTH KOREA: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 123
10.1.6 REST OF ASIA PACIFIC 123
TABLE 100 REST OF ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 123
TABLE 101 REST OF ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 102 REST OF ASIA PACIFIC: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 124
10.2 LATIN AMERICA 124
TABLE 103 LATIN AMERICA: PATIENT POSITIONING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 104 LATIN AMERICA: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 105 LATIN AMERICA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 106 LATIN AMERICA: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 107 LATIN AMERICA: PATIENT POSITIONING SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 126
TABLE 108 LATIN AMERICA: PATIENT POSITIONING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.2.1 BRAZIL 126
10.2.1.1 Minimal trade barriers for laboratory equipment to support market growth 126
TABLE 109 BRAZIL: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127
TABLE 110 BRAZIL: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 111 BRAZIL: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 127
10.2.2 MEXICO 128
10.2.2.1 Rising investments in advanced medical equipment to support market growth 128
TABLE 112 MEXICO: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 128
TABLE 113 MEXICO: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 114 MEXICO: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 129
10.2.3 REST OF LATIN AMERICA 129
TABLE 115 REST OF LATIN AMERICA: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 129
TABLE 116 REST OF LATIN AMERICA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 117 REST OF LATIN AMERICA: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 130
10.3 MIDDLE EAST & AFRICA 130
10.3.1 RISING ECONOMIC GROWTH DUE TO INCREASING INVESTMENTS IN HEALTHCARE TO DRIVE MARKET 130
TABLE 118 MIDDLE EAST & AFRICA: PATIENT POSITIONING SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131
TABLE 119 MIDDLE EAST & AFRICA: PATIENT POSITIONING SYSTEMS MARKET FOR TABLES, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 120 MIDDLE EAST & AFRICA: PATIENT POSITIONING SYSTEMS MARKET FOR ACCESSORIES, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 121 MIDDLE EAST & AFRICA: PATIENT POSITIONING SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 132
TABLE 122 MIDDLE EAST & AFRICA: PATIENT POSITIONING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION) 132
11 COMPETITIVE LANDSCAPE 133
11.1 OVERVIEW 133
11.2 KEY PLAYER STRATEGIES 133
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN PATIENT POSITIONING SYSTEMS MARKET 133
11.3 REVENUE SHARE ANALYSIS 133
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN PATIENT POSITIONING SYSTEMS MARKET 134
11.4 MARKET SHARE ANALYSIS 134
FIGURE 28 GLOBAL PATIENT POSITIONING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2021 135
TABLE 123 PATIENT POSITIONING SYSTEMS MARKET: DEGREE OF COMPETITION 135
11.5 COMPANY EVALUATION QUADRANT 136
11.5.1 STARS 136
11.5.2 EMERGING LEADERS 136
11.5.3 PERVASIVE PLAYERS 137
11.5.4 PARTICIPANTS 137
FIGURE 29 PATIENT POSITIONING SYSTEMS MARKET: COMPANY EVALUATION QUADRANT, 2021 137
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021) 138
11.6.1 PROGRESSIVE COMPANIES 138
11.6.2 STARTING BLOCKS 138
11.6.3 RESPONSIVE COMPANIES 138
11.6.4 DYNAMIC COMPANIES 138
FIGURE 30 PATIENT POSITIONING SYSTEM MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 139
11.7 COMPETITIVE BENCHMARKING 140
TABLE 124 PATIENT POSITIONING SYSTEMS MARKET: PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS 140
TABLE 125 COMPANY PRODUCT FOOTPRINT 140
TABLE 126 COMPANY REGIONAL FOOTPRINT 141
11.8 COMPETITIVE SITUATION AND TRENDS 141
TABLE 127 PRODUCT LAUNCHES 142
TABLE 128 DEALS 142
TABLE 129 OTHER DEVELOPMENTS 143
12 COMPANY PROFILES 144
12.1 KEY PLAYERS 144
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 GETINGE AB 144
TABLE 130 GETINGE AB: COMPANY OVERVIEW 144
FIGURE 31 GETINGE AB: COMPANY SNAPSHOT (2021) 145
12.1.2 HILL-ROM HOLDINGS, INC. 148
TABLE 131 HILL-ROM HOLDINGS, INC.: COMPANY OVERVIEW 148
FIGURE 32 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2021) 149
12.1.3 C-RAD 151
TABLE 132 C-RAD: COMPANY OVERVIEW 151
FIGURE 33 C-RAD: COMPANY SNAPSHOT (2021) 152
12.1.4 STRYKER CORPORATION 155
TABLE 133 STRYKER CORPORATION: COMPANY OVERVIEW 155
FIGURE 34 STRYKER CORPORATION.: COMPANY SNAPSHOT (2021) 156
12.1.5 ELEKTA AB 159
TABLE 134 ELEKTA AB: COMPANY OVERVIEW 159
FIGURE 35 ELEKTA AB: COMPANY SNAPSHOT (2022) 160
12.1.6 STERIS PLC 163
TABLE 135 STERIS PLC: COMPANY OVERVIEW 163
FIGURE 36 STERIS PLC: COMPANY SNAPSHOT (2021) 164
12.1.7 SMITH & NEPHEW PLC 167
TABLE 136 SMITH & NEPHEW PLC.: COMPANY OVERVIEW 167
FIGURE 37 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021) 168
12.1.8 LEONI AG 169
TABLE 137 LEONI AG: COMPANY OVERVIEW 169
FIGURE 38 LEONI AG: COMPANY SNAPSHOT (2021) 170
12.1.9 MERIVAARA CORP. 171
TABLE 138 MERIVAARA CORP.: COMPANY OVERVIEW 171
12.1.10 MIZUHO OSI 172
TABLE 139 MIZUHO OSI: COMPANY OVERVIEW 172
12.1.11 FAMED ZYWIEC SP. Z O.O. 174
TABLE 140 FAMED ZYWIEC SP. Z O.O.: COMPANY OVERVIEW 174
12.1.12 ONCOTECH 175
TABLE 141 ONCOTECH.: COMPANY OVERVIEW 175
12.1.13 ORFIT INDUSTRIES 178
TABLE 142 ORFIT INDUSTRIES: COMPANY OVERVIEW 178
12.1.14 GUANGZHOU RENFU MEDICAL EQUIPMENT CO, LTD 180
TABLE 143 GUANGZHOU RENFU MEDICAL EQUIPMENT CO, LTD: COMPANY OVERVIEW 180
12.1.15 CIVCO RADIOTHERAPY 181
TABLE 144 CIVCO RADIOTHERAPY: COMPANY OVERVIEW 181
12.1.16 MEDLINE INDUSTRIES, LP 183
TABLE 145 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 183
12.1.17 MEDTRONIC 185
TABLE 146 MEDTRONIC: COMPANY OVERVIEW 185
FIGURE 39 MEDTRONIC: COMPANY SNAPSHOT (2021) 185
12.1.18 SPAN AMERICA. 187
TABLE 147 SPAN AMERICA.: COMPANY OVERVIEW 187
12.2 OTHER COMPANIES 189
12.2.1 OPT SURGISYSTEMS S.R.L. 189
12.2.2 ONCOLOGY SYSTEMS LIMITED. 190
12.2.3 PROBED MEDICAL TECHNOLOGIES INC. 190
12.2.4 ALVO MEDICAL 191
12.2.5 GENDRON INC. 191
12.2.6 PARAMOUNT BED CO., LTD. 192
12.2.7 ESCHMANN TECHNOLOGIES LTD. 193
12.2.8 MEDIFA-HESSE GMBH & CO. KG 194
12.2.9 XODUS MEDICAL INC. 194
12.2.10 MEDILAND ENTERPRISE CORPORATION 195
12.2.11 INNOVATIVE MEDICAL PRODUCTS INC. 195
12.2.12 GF HEALTH PRODUCTS, INC. 196
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 197
13.1 DISCUSSION GUIDE 197
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 200
13.3 CUSTOMIZATION OPTIONS 202
13.4 RELATED REPORTS 202
13.5 AUTHOR DETAILS 203